# Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/safety-considerations-for-container-labels-and-carton-labeling-design-to-minimize-medication-errors/e13010c8-daa7-439e-bd49-fa88d08456a3

> FDA guidance document: Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors. Issue date: May 18, 2022. Get complete insights and analysis.

---

## Details

- Title: Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-05-18
- Last Changed: 2022-05-18
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-D-0401">FDA-2013-D-0401</a>

## Related Documents

- [Clinical Pharmacology Considerations for Antibody-Drug Conjugates  Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-antibody-drug-conjugates-guidance-for-industry-guidance-for-industry/ee3ed09c-6580-489f-bb06-0e93f612d604)
- [General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/general-clinical-pharmacology-considerations-for-neonatal-studies-for-drugs-and-biological-products-guidance-for-industry/0c57731e-55bc-4962-a619-54444aa22335)
- [Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Annex](https://www.globalkeysolutions.net/guidances/guidance-document/q12-technical-and-regulatory-considerations-for-pharmaceutical-product-lifecycle-management-annex/5379f689-7e71-423b-b00d-e8c8654bbd0b)